|Bid||1.2100 x 1000|
|Ask||1.4500 x 800|
|Day's Range||1.2900 - 1.3700|
|52 Week Range||1.1700 - 7.1500|
|Beta (5Y Monthly)||1.07|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 07, 2022 - Nov 11, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||6.00|
Subscribe to Yahoo Finance Plus to view Fair Value for RMTI
WIXOM, Mich., September 14, 2022--Rockwell Medical, Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the "Company"), a commercial healthcare company focused on providing life-sustaining products for patients suffering from blood disorders and diseases associated with the kidney, today announced that the Compensation Committee of the Company’s Board of Directors approved the grant of stock options to purchase an aggregate of 66,000 shares of the Company’s common stock to three new employees (the "Induc
WIXOM, Mich., September 07, 2022--As SVP, Chief Corporate Affairs Officer, Heather is responsible for IR, PR, government affairs, patient advocacy, communications, and branding.
How far off is Rockwell Medical, Inc. ( NASDAQ:RMTI ) from its intrinsic value? Using the most recent financial data...